Derrick Steven C, Yabe Idalia, Morris Sheldon, Cowley Siobhan
Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland, USA
National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
Clin Vaccine Immunol. 2016 Jul 5;23(7):638-47. doi: 10.1128/CVI.00232-16. Print 2016 Jul.
Earlier studies aimed at defining protective immunity induced by Mycobacterium bovis BCG immunization have largely focused on the induction of antituberculosis CD4(+) and CD8(+) T cell responses. Here we describe a vaccine consisting of a BCGΔmmaA4 deletion mutant formulated in dimethyl dioctadecyl-ammonium bromide (DDA) with d-(+)-trehalose 6,6'-dibehenate (TDB) (DDA/TDB) adjuvant (A4/Adj) that protected TCRδ(-/-) mice depleted of CD4(+), CD8(+), and NK1.1(+) T cells against an aerosol challenge with M. tuberculosis These mice were significantly protected relative to mice immunized with a nonadjuvanted BCGΔmmaA4 (BCG-A4) mutant and nonvaccinated controls at 2 months and 9 months postvaccination. In the absence of all T cells following treatment with anti-Thy1.2 antibody, the immunized mice lost the ability to control the infection. These results indicate that an unconventional T cell population was mediating protection in the absence of CD4(+), CD8(+), NK1.1(+), and TCRγδ T cells and could exhibit memory. Focusing on CD4(-) CD8(-) double-negative (DN) T cells, we found that these cells accumulated in the lungs postchallenge significantly more in A4/Adj-immunized mice and induced significantly greater frequencies of pulmonary gamma interferon (IFN-γ)-producing cells than were seen in the nonvaccinated or nonadjuvanted BCG control groups. Moreover, pulmonary DN T cells from the A4/Adj group exhibited significantly higher IFN-γ integrated median fluorescence intensity (iMFI) values than were seen in the control groups. We also showed that enriched DN T cells from mice immunized with A4/Adj could control mycobacterial growth in vitro significantly better than naive whole-spleen cells. These results suggest that formulating BCG in DDA/TDB adjuvant confers superior protection in immunocompromised mice and likely involves the induction of long-lived memory DN T cells.
早期旨在确定牛分枝杆菌卡介苗免疫诱导的保护性免疫的研究主要集中在抗结核 CD4(+) 和 CD8(+) T 细胞反应的诱导上。在此,我们描述了一种疫苗,其由在二甲基二十八烷基溴化铵(DDA)中配制的卡介苗ΔmmaA4缺失突变体与d-(+)-海藻糖6,6'-二山嵛酸酯(TDB)(DDA/TDB)佐剂(A4/Adj)组成,该疫苗可保护CD4(+)、CD8(+) 和 NK1.1(+) T 细胞耗竭的TCRδ(-/-) 小鼠免受结核分枝杆菌气溶胶攻击。与用无佐剂的卡介苗ΔmmaA4(BCG-A4)突变体免疫的小鼠和未接种疫苗的对照组相比,这些小鼠在接种疫苗后2个月和9个月时受到了显著保护。在用抗Thy1.2抗体处理后所有T细胞均缺失的情况下,免疫的小鼠失去了控制感染的能力。这些结果表明,在没有CD4(+)、CD8(+)、NK1.1(+) 和TCRγδ T细胞的情况下,一种非常规T细胞群体介导了保护作用,并且可以表现出记忆性。聚焦于CD4(-) CD8(-) 双阴性(DN)T细胞,我们发现这些细胞在攻击后在A4/Adj免疫的小鼠肺中积累得明显更多,并且诱导产生肺部γ干扰素(IFN-γ)的细胞频率明显高于未接种疫苗或无佐剂的卡介苗对照组。此外,A4/Adj组的肺部DN T细胞表现出的IFN-γ整合中位荧光强度(iMFI)值明显高于对照组。我们还表明,用A4/Adj免疫的小鼠富集的DN T细胞在体外控制分枝杆菌生长的能力明显优于未处理的全脾细胞。这些结果表明,在DDA/TDB佐剂中配制卡介苗可在免疫受损小鼠中提供更好的保护,并且可能涉及诱导长寿记忆性DN T细胞。